NEW YORK (GenomeWeb News) – Martin Madaus will take the CEO and chairman posts at Ortho Clinical Diagnostics upon the closure of The Carlyle Group's acquisition of OCD from Johnson and Johnson, which is expected to be mid-2014, OCD said this week.

Madaus recently was president, chairman, and CEO of Millipore, and is currently executive chairman of Quanterix's board of directors. He also is a director at Carlyle's portfolio companies PPD, Mettler Toledo, and Covidien.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.